Ensuring Informed Decision-Making for Cancer Screening

References

1. 1.↵
   American Cancer Society advertisement, “If you haven't had a mammogram you need more than your breasts examine”. Available at: https://www.latimes.com/science/sciencenow/la-sci-sn-breast-cancer-screening-mammograms-20161012-snap-story.html. Accessed November 24, 2019.
2. 2.↵
   1. Raffle AE,
   2. Mackie A,
   3. Gray JAM

   . Screening Evidence and Practice. Oxford University Press; 2007;215–256.
3. 3.↵
   1. Marmot MG,
   2. Altman DG,
   3. Cameron DA,
   4. Dewar JA,
   5. Thompson SG,
   6. Wilcox M

   . The benefits and harms of breast cancer screening: an independent review. Br J Cancer 2013;108:2205–40.

   OpenUrlCrossRefPubMedWeb of Science
4. 4.↵
   1. Kirsh VA,
   2. Chiarelli AM,
   3. Edwards SA,
   4. et al

   . Tumor characteristics associated with mammographic detection of breast cancer in the Ontario breast screening program. J Natl Cancer Inst 2011;103:942–50.

   OpenUrlCrossRefPubMedWeb of Science
5. 5.↵
   1. Baum M

   . Harms from breast cancer screening outweigh benefits if death caused by treatment is included. BMJ 2013;346:f385.

   OpenUrlFREE Full Text
6. 6.↵
   1. Prasad V,
   2. Lenzer J,
   3. Newman DH

   . Why cancer screening has never been shown to “save lives”—and what we can do about it. BMJ 2016;352:h6080.

   OpenUrlFREE Full Text
7. 7.↵
   1. McCartney M

   . Margaret McCartney: Can we now talk openly about the risks of screening? BMJ 2018;361:k2055.

   OpenUrlFREE Full Text
8. 8.↵
   1. Welch HG

   . The heterogeneity of cancer. Breast Cancer Res Treat 2018;169:207–8.

   OpenUrl
9. 9.↵
   1. Wegwarth O,
   2. Schwartz LM,
   3. Woloshin S,
   4. Gaissmaier W,
   5. Gigerenzer G

   . Do Physicians Understand Cancer Screening Statistics? A National Survey of Primary Care Physicians in the United States. Ann Intern Med 2012;156:340–9.

   OpenUrlCrossRefPubMedWeb of Science
10. 10.↵
    1. Fletcher SW

    . Whither Scientific Deliberation in Health Policy Recommendations? — Alice in the Wonderland of Breast-Cancer Screening. N Engl J Med 1997;336:1180–3.

    OpenUrlCrossRefPubMedWeb of Science
11. 11.↵
    National Health Service. PSA testing prostate cancer. 2018. Available at: https://www.nhs.uk/conditions/prostate-cancer/psa-testing/. Accessed August 25, 2020.
12. 12.↵
    1. Wise J

    . Mobile lung cancer testing in supermarket car parks is to be expanded. BMJ 2017;359:j5450.

    OpenUrlFREE Full Text
13. 13.↵
    1. Mahase E

    . Will genome testing of healthy babies save lives? BMJ 2019;367:l6449.

    OpenUrlFREE Full Text
14. 14.↵
    Fixing the present building for the future: newborn screening for rare conditions. 2019. Available at: http://www.geneticalliance.org.uk/wp-content/uploads/2019/07/FIXING-THE-PRESENT-BUILDING-FOR-THE-FUTURE-Newborn-screening-for-rare-conditions-.pdf. Accessed 24 Nov 2019.
15. 15.↵
    Detailed ACR Statement on Ill-Advised and Dangerous USPSTF Mammography Recommendations. 2009. Available at: https://www.acr.org/Advocacy-and-Economics/ACR-Position-Statements/Ill-Advised-and-Dangerous-USPSTF-Mammography-Recommendations. Accessed 06 May 2020.
16. 16.↵
    1. McCartney M

    . Cancer screening review diminishes informed choice., BMJ 2019;367:l6224.

    OpenUrlFREE Full Text
17. 17.↵
    1. Richards M

    . Report of the independent review of adult screening programmes in England. 2019. Available at: https://www.england.nhs.uk/wp-content/uploads/2019/02/report-of-the-independent-review-of-adult-screening-programme-in-england.pdf. Accessed August 25, 2020.
18. 18.↵
    1. Smith SK,
    2. Trevena L,
    3. Simpson JM,
    4. Barratt A,
    5. Nutbeam D,
    6. McCaffery KJ

    . A decision aid to support informed choices about bowel cancer screening among adults with low education: randomised controlled trial. BMJ 2010;341:c5370.

    OpenUrlAbstract/FREE Full Text
19. 19.↵
    1. Spiegelhalter DJ

    . Understanding uncertainty. Ann Fam Med 2008;6:196–7.

    OpenUrlFREE Full Text
20. 20.↵
    Lung cancer-1000 person tool. https://canadiantaskforce.ca/tools-resources/lung-cancer-2/lung-cancer-for-patients/. Accessed November 24, 2019.
21. 21.↵
    1. Scalia P,
    2. Durand M-A,
    3. Faber M,
    4. Kremer JA,
    5. Song J,
    6. Elwyn G

    . User-testing an interactive option grid decision aid for prostate cancer screening: lessons to improve usability. BMJ Open 2019;9:e026748.

    OpenUrlAbstract/FREE Full Text
22. 22.↵
    NHS breast screening: helping you decide. Available at: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/840343/Breast_screening_helping_you_decide.pdf. Accessed August 25, 2020.
23. 23.↵
    1. Rychetnik L,
    2. Carter SM,
    3. Abelson J,
    4. et al

    . Enhancing citizen engagement in cancer screening through deliberative democracy. J Natl Cancer Inst 2013;105:380–6.

    OpenUrlCrossRefPubMed
24. 24.↵
    1. Mosconi P,
    2. Colombo C,
    3. Satolli R,
    4. Carzaniga C

    . Involving a citizens' jury in decisions on individual screening for prostate cancer. PLOS ONE 2016;11(1):e0143176.

    OpenUrlCrossRefPubMed
25. 25.↵
    1. Wise J

    . Citizens' juries for health policy. BMJ 2017;357:j2650.

    OpenUrlFREE Full Text
26. 26.↵
    1. Degeling C,
    2. Barratt A,
    3. Aranda S,
    4. et al

    . Should women aged 70–74 be invited to participate in screening mammography? A report on two Australian community juries. BMJ Open 2018;8:e021174.

    OpenUrlAbstract/FREE Full Text
27. 27.↵
    The Jefferson Centre, citizens juries. https://jefferson-center.org/about-us/how-we-work/. Accessed November 25, 2019.